Copyright
©The Author(s) 2023.
World J Gastroenterol. May 14, 2023; 29(18): 2836-2849
Published online May 14, 2023. doi: 10.3748/wjg.v29.i18.2836
Published online May 14, 2023. doi: 10.3748/wjg.v29.i18.2836
Table 1 The clinical information of de novo and carcinoma in adenoma colorectal cancers
| De novo (n = 33) | CIA (n = 30) | χ2 | P value | ||
| Clinical information | |||||
| Age (%) | > 55 | 30 (90.9) | 25 (83.3) | 0.814 | > 0.05 |
| < 55 | 3 (9.1) | 5 (16.7) | |||
| Gender (%) | Male | 16 (48.5) | 16 (53.3) | 0.148 | > 0.05 |
| Female | 17 (51.5) | 14 (46.7) | |||
| Smoking history (%) | Yes | 27 (81.8) | 19 (63.3) | 2.725 | > 0.05 |
| No | 6 (18.2) | 11 (36.7) | |||
| Location (%) | Proximal | 7 (21.2) | 21 (70.0) | 15.149 | < 0.05 |
| Distal | 26 (78.8) | 9 (30.0) | |||
| Depth of invasion | M | 8 (24.2) | 9 (30.0) | 1.504 | > 0.05 |
| SMp | 9 (27.3) | 11 (36.7) | |||
| SMd | 16 (48.5) | 10 (33.3) | |||
| Treatment (%) | Surgery | 21 (63.6) | 16 (53.3) | 0.688 | > 0.05 |
| Endoscopy | 12 (36.4) | 14 (46.7) | |||
| Supplement chemotherapy (%) | Yes | 21 (63.6) | 12 (40.0) | 3.520 | > 0.05 |
| No | 12 (36.4) | 18 (60.0) | |||
| Distal metastasis (%) | Yes | 5 (15.2) | 2 (6.7) | 1.145 | > 0.05 |
| No | 28 (84.8) | 28 (93.3) | |||
| Overall survival (%) | 1 yr | 33 (100.0) | 30 (100.0) | ||
| 3 yr | 30 (90.9) | 28 (93.3) | |||
| 5 yr | 23 (69.7) | 28 (93.3) | |||
| DSS | Yes | 26 (78.8) | 28 (93.3) | 2.715 | > 0.05 |
| No | 7 (21.2) | 2 (6.7) | |||
| Endoscopic gross characteristics | |||||
| Size% | 1 cm < S ≤ 2 cm | 14 (42.4) | 9 (30.0) | 30.514 | < 0.05 |
| ≤ 1 cm | 16 (48.5) | 0 (0.0) | |||
| > 2 cm | 3 (9.1) | 21 (70.0) | |||
| Macroscopic type% | Is | 5 (15.2) | 6 (20.0) | 35.187 | < 0.05 |
| IIa + IIc | 11 (33.3) | 1 (3.3) | |||
| IIc | 17 (51.5) | 4 (13.3) | |||
| Is + IIc | 0 (0.0) | 19 (63.3) | |||
| Surface change | Erosion | 24 (72.7) | 13 (43.3) | 9.457 | < 0.05 |
| Ulceration | 2 (6.1) | 11 (36.7) | |||
| None | 7 (21.2) | 6 (20.0) | |||
| Color change | Reddened mucosa | 26 (78.8) | 2 (6.7) | 33.104 | < 0.05 |
| None | 7 (21.2) | 28 (93.3) | |||
| NICE | Type 1 | 0 (0.0) | 0 (0.0) | > 0.05 | |
| Type 2 | 0 (0.0) | 0 (0.0) | |||
| Type 3 | 33 (100.0) | 30 (100.0) | |||
| Sano | I | 0 (0.0) | 0 (0.0) | 5.292 | < 0.05 |
| II | 0 (0.0) | 0 (0.0) | |||
| IIIA | 17 (51.5) | 7 (23.3) | |||
| IIIB | 16 (48.5) | 23 (76.7) | |||
| JNET | 1 | 0 (0.0) | 0 (0.0) | 3.094 | > 0.05 |
| 2A | 0 (0.0) | 0 (0.0) | |||
| 2B | 12 (36.4) | 5 (16.7) | |||
| 3 | 21 (63.6) | 25 (83.3) | |||
| Chemical staining (crystal violet) | |||||
| Pit pattern | Vi | 1 (3.0) | 6 (20.0) | 15.774 | < 0.05 |
| Vn | 13 (39.4) | 15 (50.0) | |||
| Vi + Vn | 19 (57.6) | 5 (16.7) | |||
| IV + Vi | 0 (0.0) | 4 (13.3) | |||
| Pit pattern at the edge of the tumors | I | 33 (100.0) | 0 (0.0) | 63.000 | < 0.05 |
| III + VI | 0 (0.0) | 30 (100.0) | |||
| Surrounding mucosa | |||||
| Pulling | Yes | 9 (27.3) | 21 (70.0) | 11.501 | < 0.05 |
| No | 24 (72.7) | 9 (30.0) | |||
| Converging folds | Yes | 27 (81.8) | 15 (50.0) | 7.159 | < 0.05 |
| No | 6 (18.2) | 15 (50.0) | |||
| CSM | CSM1 | 11 (33.3) | 4 (13.3) | 3.553 | > 0.05 |
| CSM2 | 17 (51.5) | 21 (70.0) | |||
| CSM3 | 5 (15.2) | 5 (16.7) |
Table 2 The endoscopic characteristics in de novo and carcinoma in adenoma groups
| De novo (n = 22) | CIA (n = 20) | χ2 | P value | ||
| Budding | BD1 | 8 (24.2) | 4 (13.3) | 6.161 | > 0.05 |
| BD2 | 8 (24.2) | 6 (20.0) | |||
| BD3 | 11 (33.3) | 6 (20.0) | |||
| None | 5 (18.2) | 14 (46.7) | |||
| Grading | G1 | 6 (18.2) | 13 (43.3) | 8.878 | > 0.05 |
| G2 | 11 (33.3) | 9 (30.0) | |||
| G1-2 | 10 (30.3) | 8 (26.7) | |||
| G3-2 | 6 (18.2) | 0 (0.0) | |||
| TIL | Yes | 27 (81.8) | 19 (63.3) | 2.725 | > 0.05 |
| No | 6 (18.2) | 11 (36.7) | |||
| Perineural infiltration | Yes | 16 (48.5) | 3 (10.0) | 11.050 | < 0.05 |
| No | 17 (51.5) | 27 (90.0) | |||
| Lymphovascular invasion | Yes | 16 (48.5) | 7 (23.3) | 4.289 | < 0.05 |
| No | 17 (51.5) | 23 (76.7) | |||
| Growth pattern | INFa | 0 (0.0) | 27 (90.0) | 63.000 | < 0.05 |
| INFb | 0 (0.0) | 3 (10.0) | |||
| INFc | 33 (100.0) | 0 (0.0) | |||
| Lymph node metastasis | Yes | 10 (30.3) | 1 (3.3) | 7.931 | > 0.05 |
| No | 23 (69.7) | 29 (96.7) | |||
| Adjacent lesions | Inflammation | 33 (100.0) | 0 (0.0) | 63.000 | < 0.05 |
| Adenoma | 0 (0.0) | 17 (56.7) | |||
| Hyperplasia | 0 (0.0) | 13 (43.3) | |||
| IHC-E-cadherin | No staining | 0 (0.0) | 0 (0.0) | 22.609 | < 0.05 |
| Weak | 17 (51.5) | 2 (6.7) | |||
| Moderate | 15 (48.5) | 19 (63.3) | |||
| Strong | 0 (0.0) | 9 (30.0) | |||
| IHC-Vimentin | No staining | 0 (0.0) | 0 (0.0) | 23.182 | < 0.05 |
| Weak | 13 (39.4) | 18 (60.0) | |||
| Moderate | 1 (3.0) | 10 (33.3) | |||
| Strong | 19 (57.6) | 2 (6.7) |
Table 3 The risk factors are related to the depth of invasion
| Depth of invasion | M | SM-S | SM-d and deeper | r | P value |
| Size, % | -0.002 | > 0.05 | |||
| 1 cm < S ≤ 2 cm | 1 (12.5) | 0 (0.0) | 13 (81.3) | ||
| ≤ 1 cm | 7 (87.5) | 9 (100.0) | 0 (0.0) | ||
| > 2 cm | 0 (0.0) | 0 (0.0) | 3 (18.8) | ||
| Growth pattern | > 0.05 | ||||
| IFNa | 0 (0.0) | 0 (0.0) | 0 (0.0) | ||
| IFNb | 0 (0.0) | 0 (0.0) | 0 (0.0) | ||
| IFNc | 8 (100.0) | 9 (100.0) | 16 (100.0) | ||
| Differential degree | 0.904 | < 0.001 | |||
| G1 | 5 (62.5) | 1 (11.1) | 0 (0.0) | ||
| G2 | 3 (37.5) | 8 (88.9) | 0 (0.0) | ||
| G1-2 | 0 (0.0) | 0 (0.0) | 10 (62.5) | ||
| G3-2 | 0 (0.0) | 0 (0.0) | 6 (37.5) | ||
| Macroscopic type | -0.093 | > 0.05 | |||
| Is | 2 (25.0) | 0 (0.0) | 13 (81.3) | ||
| IIa + IIc | 6 (75.0) | 9 (100.0) | 0 (0.0) | ||
| IIc | 0 (0.0) | 0 (0.0) | 3 (18.8) | ||
| Is + IIc | 0 (0.0) | 0 (0.0) | 0 (0.0) | ||
| NICE | > 0.05 | ||||
| Type 1 | 0 (0.0) | 0 (0.0) | 0 (0.0) | ||
| Type 2 | 0 (0.0) | 0 (0.0) | 0 (0.0) | ||
| Type 3 | 8 (100.0) | 9 (100.0) | 16 (100.0) | ||
| Sano | 0.938 | < 0.001 | |||
| I | 0 (0.0) | 0 (0.0) | 0 (0.0) | ||
| II | 0 (0.0) | 0 (0.0) | 0 (0.0) | ||
| IIIA | 8 (100.0) | 9 (100.0) | 0 (0.0) | ||
| IIIB | 0 (0.0) | 0 (0.0) | 16 (100.0) | ||
| JNET | 0.649 | < 0.001 | |||
| 1 | 0 (0.0) | 0 (0.0) | 0 (0.0) | ||
| 2A | 0 (0.0) | 0 (0.0) | 0 (0.0) | ||
| 2B | 5 (62.5) | 7 (77.8) | 0 (0.0) | ||
| 3 | 3 (37.5) | 2 (22.2) | 16 (100.0) | ||
| Pit pattern | -0.491 | < 0.001 | |||
| Vi | 1 (12.5) | 0 (0.0) | 0 (0.0) | ||
| Vn | 0 (0.0) | 0 (0.0) | 13 (81.3) | ||
| Vi + Vn | 7 (87.5) | 9 (100.0) | 3 (18.8) | ||
| IV + Vi | 0 (0.0) | 0 (0.0) | 0 (0.0) | ||
| Pit pattern at the edge of the tumors | > 0.05 | ||||
| I | 8 (100.0) | 9 (100.0) | 16 (100.0) | ||
| III + VI | 0 (0.0) | 0 (0.0) | 0 (0.0) | ||
| Surrounding mucosa | |||||
| Pulling | -0.567 | < 0.001 | |||
| Yes | 0 (0.0) | 0 (0.0) | 9 (56.3) | ||
| No | 8 (100.0) | 9 (100.0) | 7 (43.8) | ||
| Converging folds | -0.62 | < 0.001 | |||
| Yes | 3 (37.5) | 8 (88.9) | 16 (100.0) | ||
| No | 5 (62.5) | 1 (11.1) | 0 (0.0) | ||
| CSM | -0.796 | < 0.001 | |||
| CSM1 | 0 (0.0) | 0 (0.0) | 11 (68.8) | ||
| CSM2 | 3 (37.5) | 9 (100.0) | 5 (31.3) | ||
| CSM3 | 5 (62.5) | 0 (0.0) | 0 (0.0) |
Table 4 The risk factors are related to tumor budding
| BD1 | BD2 | BD3 | No budding | r | P value | |
| Infiltrative depth, % | 0.669 | < 0.001 | ||||
| M | 0 (0.0) | 3 (21.4) | 0 (0.0) | 14 (70.0) | ||
| SMp | 10 (83.3) | 1 (7.1) | 3 (17.6) | |||
| SMd | 2 (16.7) | 10 (71.4) | 14 (82.4) | |||
| Lymphovascular invasion | 0.663 | < 0.001 | ||||
| Yes | 2 (28.6) | 4 (21.1) | 16 (94.1) | 1 (5.0) | ||
| No | 5 (71.4) | 15 (78.9) | 1 (5.9) | 19 (95.0) | ||
| Lymph node metastasis | 0.489 | < -0.001 | ||||
| Yes | 1 (14.3) | 1 (5.3) | 9 (52.9) | 0 (0.0) | ||
| No | 6 (85.7) | 18 (94.7) | 8 (41.7) | 20 (100.0) | ||
| Perineural infiltration | 0.601 | < 0.001 | ||||
| Yes | 2 (28.6) | 4 (21.1) | 13 (76.5) | 0 (0.0) | ||
| No | 5 (71.4) | 15 (78.9) | 4 (23.5) | 20 (100.0) | ||
| Tumor infiltrating lymphocytes | 0.476 | < 0.001 | ||||
| Yes | 7 (100.0) | 19 (100.0) | 14 (82.4) | 6 (30.0) | ||
| No | 0 (0.0) | 0 (0.0) | 3 (17.6) | 14 (70.0) | ||
| Differential degree | 0.706 | < 0.001 | ||||
| G1 | 0 (0.0) | 0 (0.0) | 0 (0.0) | 19 (95.0) | ||
| G1-2 | 2 (28.6) | 9 (47.4) | 7 (41.2) | 0 (0.0) | ||
| G2 | 5 (71.4) | 10 (52.6) | 4 (23.5) | 1 (5.0) | ||
| G3-2 | 0 (0.0) | 0 (0.0) | 6 (35.3) | 0 (0.0) |
- Citation: Li SY, Yang MQ, Liu YM, Sun MJ, Zhang HJ. Endoscopic and pathological characteristics of de novo colorectal cancer: Retrospective cohort study. World J Gastroenterol 2023; 29(18): 2836-2849
- URL: https://www.wjgnet.com/1007-9327/full/v29/i18/2836.htm
- DOI: https://dx.doi.org/10.3748/wjg.v29.i18.2836
